---
document_datetime: 2026-01-06 10:08:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/voriconazole-hikma.html
document_name: voriconazole-hikma.html
version: success
processing_time: 0.1419385
conversion_datetime: 2026-01-10 11:32:47.060194
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.1
  docling: 2.67.0
  docling-core: 2.58.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Voriconazole Hikma (previously Voriconazole Hospira)

[RSS](/en/individual-human-medicine.xml/65661)

##### Authorised

This medicine is authorised for use in the European Union

voriconazole Medicine Human Authorised

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Voriconazole Hikma (previously Voriconazole Hospira)](#news-on)
- [More information on Voriconazole Hospira](#more-information-on-voriconazole-hospira-1042)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

This is a summary of the European public assessment report (EPAR) for Voriconazole Hikma. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Voriconazole Hikma.

For practical information about using Voriconazole Hikma, patients should read the package leaflet or contact their doctor or pharmacist.

Expand section

Collapse section

## What is Voriconazole Hikma and what is it used for?

Voriconazole Hikma is an antifungal medicine used for the treatment of adults and children over the age of two years who have the following infections caused by a fungus:

- invasive aspergillosis (a type of fungal infection due to Aspergillus);
- candidaemia (a type of fungal infection due to Candida) in patients with a normal white blood cell count;
- other serious invasive Candida infections when the fungus is resistant to fluconazole (another antifungal medicine);
- serious fungal infections caused by Scedosporium or Fusarium (two different types of fungus).

When used for treating fungal infections, Voriconazole Hikma is intended mainly for patients with infections that are worsening and possibly life-threatening.

Voriconazole Hikma is also used to prevent fungal infections in patients who have had haematopoietic (blood) stem-cell transplantation (a transplant of a type of stem cells that can develop into blood cells) and are at high risk of infection.

Voriconazole Hikma contains the active substance voriconazole. It is a 'generic medicine'. This means that Voriconazole Hikma is similar to a 'reference medicine' already authorised in the European Union (EU) called Vfend. For more information on generic medicines, see the question-and-answer document here.

## How is Voriconazole Hikma used?

Voriconazole Hikma is available as a powder to be made up into a solution for infusion (drip) into a vein. It is given twice a day. The dose of Voriconazole Hikma depends on the weight of the patient.

Patients need to receive an initial higher dose (loading dose) on the first day. The aim of the loading dose is to attain effective blood levels quickly. The loading dose is then followed by a maintenance dose that can be adjusted according to the patient's response. The dose may be increased or decreased according to how the patient responds.

Both the loading and the maintenance doses are given by infusion, but once patients improve prescribers should consider switching patients to a voriconazole medicine that can be given by mouth.

The medicine can only be obtained with a prescription.

## How does Voriconazole Hikma work?

The active substance in Voriconazole Hikma, voriconazole, belongs to the 'triazole' class of antifungal medicines. It works by disrupting the formation of ergosterol, which is an important part of fungal cell membranes. Without ergosterol, the fungus cannot spread or dies. The list of fungi against which Voriconazole Hikma is active can be found in the summary of product characteristics (also part of the EPAR).

## How has Voriconazole Hikma been studied?

As for every medicine, the company provided studies on the quality of voriconazole. There was no need for 'bioequivalence' studies to investigate whether voriconazole is absorbed similarly to the reference medicine, Vfend, to produce the same level of the active substance in the blood. This is because voriconazole is given by infusion into a vein, so the active substance is delivered straight into the bloodstream.

## What are the benefits and risks of Voriconazole Hikma?

Because Voriconazole Hikma is a generic medicine, its benefits and risks are taken as being the same as the reference medicine's.

## Why is Voriconazole Hikma approved?

The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Voriconazole Hikma has been shown to be comparable to Vfend. Therefore, the CHMP's view was that, as for Vfend, the benefit outweighs the identified risk. The Committee recommended that Voriconazole Hikma be approved for use in the EU.

## What measures are being taken to ensure the safe and effective use of Voriconazole Hikma?

A risk management plan has been developed to ensure that Voriconazole Hikma is used as safely as possible. Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Voriconazole Hikma, including the appropriate precautions to be followed by healthcare professionals and patients.

Further information can be found in the summary of the risk management plan.

## Other information about Voriconazole Hikma

The European Commission granted a marketing authorisation valid throughout the European Union for Voriconazole Hikma on 27 May 2015.

For more information about treatment with Voriconazole Hikma, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.

Voriconazole Hikma (previously Voriconazole Hospira): EPAR - Summary for the public

English (EN) (99.74 KB - PDF)

**First published:** 25/06/2015

**Last updated:** 01/03/2017

[View](/en/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-956)

български (BG) (126.13 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/bg/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_bg.pdf)

español (ES) (98.6 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/es/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_es.pdf)

čeština (CS) (123.57 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/cs/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_cs.pdf)

dansk (DA) (98.07 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/da/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_da.pdf)

Deutsch (DE) (99.75 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/de/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_de.pdf)

eesti keel (ET) (97.05 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/et/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_et.pdf)

ελληνικά (EL) (128.56 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/el/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_el.pdf)

français (FR) (99.33 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/fr/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_fr.pdf)

hrvatski (HR) (117.24 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/hr/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_hr.pdf)

italiano (IT) (97.8 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/it/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_it.pdf)

latviešu valoda (LV) (119.49 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/lv/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (121.08 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/lt/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_lt.pdf)

magyar (HU) (116.07 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/hu/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_hu.pdf)

Malti (MT) (124.09 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/mt/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_mt.pdf)

Nederlands (NL) (98.54 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/nl/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_nl.pdf)

polski (PL) (122.84 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/pl/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_pl.pdf)

português (PT) (98.75 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/pt/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_pt.pdf)

română (RO) (119.36 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/ro/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_ro.pdf)

slovenčina (SK) (121.84 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/sk/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_sk.pdf)

slovenščina (SL) (115.89 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/sl/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_sl.pdf)

Suomi (FI) (97.55 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/fi/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_fi.pdf)

svenska (SV) (98.04 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/sv/documents/overview/voriconazole-hikma-previously-voriconazole-hospira-epar-summary-public_sv.pdf)

Voriconazole Hospira : EPAR - Risk-management-plan summary

English (EN) (62.36 KB - PDF)

**First published:** 25/06/2015

**Last updated:** 25/06/2015

[View](/en/documents/rmp-summary/voriconazole-hospira-epar-risk-management-plan-summary_en.pdf)

## Product information

Voriconazole Hikma : EPAR - Product Information

English (EN) (753.1 KB - PDF)

**First published:** 25/06/2015

**Last updated:** 06/01/2026

[View](/en/documents/product-information/voriconazole-hikma-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-654)

български (BG) (1 MB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/bg/documents/product-information/voriconazole-hikma-epar-product-information_bg.pdf)

español (ES) (850.16 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/es/documents/product-information/voriconazole-hikma-epar-product-information_es.pdf)

čeština (CS) (917.77 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/cs/documents/product-information/voriconazole-hikma-epar-product-information_cs.pdf)

dansk (DA) (918.71 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/da/documents/product-information/voriconazole-hikma-epar-product-information_da.pdf)

Deutsch (DE) (992.33 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/de/documents/product-information/voriconazole-hikma-epar-product-information_de.pdf)

eesti keel (ET) (827.18 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/et/documents/product-information/voriconazole-hikma-epar-product-information_et.pdf)

ελληνικά (EL) (1.07 MB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/el/documents/product-information/voriconazole-hikma-epar-product-information_el.pdf)

français (FR) (742.14 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/fr/documents/product-information/voriconazole-hikma-epar-product-information_fr.pdf)

hrvatski (HR) (951.73 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/hr/documents/product-information/voriconazole-hikma-epar-product-information_hr.pdf)

íslenska (IS) (815.62 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/is/documents/product-information/voriconazole-hikma-epar-product-information_is.pdf)

italiano (IT) (813.07 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/it/documents/product-information/voriconazole-hikma-epar-product-information_it.pdf)

latviešu valoda (LV) (940.23 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/lv/documents/product-information/voriconazole-hikma-epar-product-information_lv.pdf)

lietuvių kalba (LT) (972.29 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/lt/documents/product-information/voriconazole-hikma-epar-product-information_lt.pdf)

magyar (HU) (993.59 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/hu/documents/product-information/voriconazole-hikma-epar-product-information_hu.pdf)

Malti (MT) (952.34 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/mt/documents/product-information/voriconazole-hikma-epar-product-information_mt.pdf)

Nederlands (NL) (913.54 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/nl/documents/product-information/voriconazole-hikma-epar-product-information_nl.pdf)

norsk (NO) (914.35 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/no/documents/product-information/voriconazole-hikma-epar-product-information_no.pdf)

polski (PL) (1.04 MB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/pl/documents/product-information/voriconazole-hikma-epar-product-information_pl.pdf)

português (PT) (846.04 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/pt/documents/product-information/voriconazole-hikma-epar-product-information_pt.pdf)

română (RO) (915.95 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/ro/documents/product-information/voriconazole-hikma-epar-product-information_ro.pdf)

slovenčina (SK) (962.57 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/sk/documents/product-information/voriconazole-hikma-epar-product-information_sk.pdf)

slovenščina (SL) (957.12 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/sl/documents/product-information/voriconazole-hikma-epar-product-information_sl.pdf)

Suomi (FI) (707.62 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/fi/documents/product-information/voriconazole-hikma-epar-product-information_fi.pdf)

svenska (SV) (855.31 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

06/01/2026

[View](/sv/documents/product-information/voriconazole-hikma-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** VR/0000310244 22/12/2025

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Voriconazole Hikma (previously Voriconazole Hospira): EPAR - All Authorised presentations

English (EN) (27.13 KB - PDF)

**First published:** 25/06/2015

**Last updated:** 01/03/2017

[View](/en/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-491)

български (BG) (29.72 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/bg/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_bg.pdf)

español (ES) (26.83 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/es/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_es.pdf)

čeština (CS) (27.67 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/cs/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (27.99 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/da/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (28.71 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/de/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (26.45 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/et/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (29.47 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/el/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_el.pdf)

français (FR) (27.02 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/fr/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (27.28 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/hr/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (28.01 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/is/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_is.pdf)

italiano (IT) (26.25 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/it/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (28 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/lv/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (27.52 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/lt/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (27.49 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/hu/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (28.21 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/mt/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (26.9 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/nl/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (28.34 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/no/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_no.pdf)

polski (PL) (28.69 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/pl/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_pl.pdf)

português (PT) (28.33 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/pt/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_pt.pdf)

română (RO) (27.72 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/ro/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (28.14 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/sk/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (26.87 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/sl/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (26.32 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/fi/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (24.59 KB - PDF)

**First published:**

25/06/2015

**Last updated:**

01/03/2017

[View](/sv/documents/all-authorised-presentations/voriconazole-hikma-previously-voriconazole-hospira-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Voriconazole Hikma (previously Voriconazole Hospira) Active substance voriconazole International non-proprietary name (INN) or common name voriconazole Therapeutic area (MeSH)

- Bacterial Infections and Mycoses
- Aspergillosis
- Candidiasis

Anatomical therapeutic chemical (ATC) code J02AC03

### Pharmacotherapeutic group

Antimycotics for systemic use

### Therapeutic indication

Voriconazole is a broad spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows:

- treatment of invasive aspergillosis;
- treatment of candidaemia in non-neutropenic patients;
- treatment of fluconazole-resistant serious invasive Candida infections (including C. krusei);
- treatment of serious fungal infections caused by Scedosporium spp. and Fusarium spp.

Voriconazole should be administered primarily to patients with progressive, possibly life-threatening infections.

Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT)

## Authorisation details

EMA product number EMEA/H/C/003737

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Hikma Farmaceutica (Portugal) S.A.

Estrada do Rio da Mo, 8, 8A-B - Fervenca 2705-906 Terrugem SNT Portugal

Opinion adopted 26/03/2015 Marketing authorisation issued 27/05/2015 Revision 16

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Voriconazole Hikma (previously Voriconazole Hospira): EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (143.64 KB - PDF)

**First published:** 06/01/2026

[View](/en/documents/procedural-steps-after/voriconazole-hikma-previously-voriconazole-hospira-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Voriconazole Hikma (previously Voriconazole Hospira): EPAR - Procedural steps taken and scientific information after authorisation (archived)

English (EN) (131.31 KB - PDF)

**First published:** 23/03/2016

**Last updated:** 20/01/2025

[View](/en/documents/procedural-steps-after/voriconazole-hikma-previously-voriconazole-hospira-epar-procedural-steps-taken-scientific-information-after-authorisation-archived_en.pdf)

## Initial marketing authorisation documents

Voriconazole Hospira : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/151531/2015

English (EN) (463.03 KB - PDF)

**First published:** 25/06/2015

**Last updated:** 25/06/2015

[View](/en/documents/assessment-report/voriconazole-hospira-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Voriconazole Hospira

Adopted

Reference Number: EMA/CHMP/189813/2015

English (EN) (140 KB - PDF)

**First published:** 27/03/2015

**Last updated:** 27/03/2015

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-voriconazole-hospira_en.pdf)

#### News on Voriconazole Hikma (previously Voriconazole Hospira)

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 March 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-23-26-march-2015) 27/03/2015

#### More information on Voriconazole Hospira

Questions and answers on generic medicines

Reference Number: EMA/393905/2006 Rev. 2

English (EN) (66.45 KB - PDF)

**First published:** 09/07/2007

**Last updated:** 07/12/2012

[View](/en/documents/other/questions-and-answers-generic-medicines_en.pdf)

[Other languages (22)](#file-language-dropdown-573)

български (BG) (93.16 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/bg/documents/other/questions-and-answers-generic-medicines_bg.pdf)

español (ES) (68.3 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/es/documents/other/questions-and-answers-generic-medicines_es.pdf)

čeština (CS) (87.71 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/cs/documents/other/questions-and-answers-generic-medicines_cs.pdf)

dansk (DA) (66.79 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/da/documents/other/questions-and-answers-generic-medicines_da.pdf)

Deutsch (DE) (67.55 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/de/documents/other/questions-and-answers-generic-medicines_de.pdf)

eesti keel (ET) (65.21 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/et/documents/other/questions-and-answers-generic-medicines_et.pdf)

ελληνικά (EL) (91.29 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/el/documents/other/questions-and-answers-generic-medicines_el.pdf)

français (FR) (68.35 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/fr/documents/other/questions-and-answers-generic-medicines_fr.pdf)

hrvatski (HR) (87.8 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/hr/documents/other/questions-and-answers-generic-medicines_hr.pdf)

italiano (IT) (67.62 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/it/documents/other/questions-and-answers-generic-medicines_it.pdf)

latviešu valoda (LV) (111.81 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/lv/documents/other/questions-and-answers-generic-medicines_lv.pdf)

lietuvių kalba (LT) (86.76 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/lt/documents/other/questions-and-answers-generic-medicines_lt.pdf)

magyar (HU) (85.76 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/hu/documents/other/questions-and-answers-generic-medicines_hu.pdf)

Malti (MT) (89.35 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/mt/documents/other/questions-and-answers-generic-medicines_mt.pdf)

Nederlands (NL) (66.81 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/nl/documents/other/questions-and-answers-generic-medicines_nl.pdf)

polski (PL) (88.51 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/pl/documents/other/questions-and-answers-generic-medicines_pl.pdf)

português (PT) (68.32 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/pt/documents/other/questions-and-answers-generic-medicines_pt.pdf)

română (RO) (86.9 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/ro/documents/other/questions-and-answers-generic-medicines_ro.pdf)

slovenčina (SK) (87.73 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/sk/documents/other/questions-and-answers-generic-medicines_sk.pdf)

slovenščina (SL) (84.8 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/sl/documents/other/questions-and-answers-generic-medicines_sl.pdf)

Suomi (FI) (66.21 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/fi/documents/other/questions-and-answers-generic-medicines_fi.pdf)

svenska (SV) (67.11 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/sv/documents/other/questions-and-answers-generic-medicines_sv.pdf)

#### Topics

- [Generic and hybrid medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A54)
- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 06/01/2026

## Share this page

[Back to top](#main-content)